Evidence map›Paper›PMID 9557875›Full record

ArticleGlycoconjugate journal1998

Purification and properties of recombinant beta-galactosidase from Bacillus circulans.

H Fujimoto, M Miyasato, Y Ito, T Sasaki, K Ajisaka

Abstract read
PubMed Publisher
In one paragraph

Article in Glycoconjugate journal, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Article
  3. Unique Glycoform-Dependent Monoclonal Antibodies for Mouse Mucin 21.International journal of molecular sciences · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

H FujimotoMeiji Institute of Health Science, Naruda Odawara, Japan. RXG01204@niftyserve.or.jp
M Miyasato
Y Ito
T Sasaki
K Ajisaka
National Institute of Health Sciences · LK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A gene encoding beta-galactosidase from Bacillus circulans which had hydrolysis specificity for the beta1-3 linkage was expressed in Escherichia coli. The beta-galactosidase was purified from crude cell lysates of E. coli by column chromatographies on Resource Q and Sephacryl S-200 HR. The enzyme released galactose with high selectivity from oligosaccharides which had terminal beta1-3 linked galactose residues. However it did not hydrolyse beta1-4 linked galactooligosaccharides. Moreover, Galbeta1-3GlcNAc, Galbeta1-3GalNAc, and their p-nitrophenyl glycosides were regioselectively synthesized in 10-46% yield by the transglycosylation reaction using this enzyme.

Indexed as

Bacillusbeta-GalactosidaseCarbohydrate ConformationCarbohydrate SequenceDisaccharidesGlycosylationHydrogen-Ion ConcentrationHydrolysisIsoelectric PointKineticsMolecular Sequence DataMolecular WeightOligosaccharidesRecombinant ProteinsSubstrate SpecificityTemperaturebeta-GalactosidaseDisaccharidesOligosaccharidesRecombinant Proteins

Identifiers

PMID9557875
OpenAlexW2911450783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.